Fortress Biotech Inc (NASDAQ: FBIO) on Tuesday, soared 4.02% from the previous trading day, before settling in for the closing price of $1.74. Within the past 52 weeks, FBIO’s price has moved between $1.36 and $4.43.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 26.66%. The company achieved an average annual earnings per share of 58.60%. With a float of $21.93 million, this company’s outstanding shares have now reached $27.58 million.
Considering the fact that the conglomerate employs 186 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 59.95%, operating margin of -169.77%, and the pretax margin is -162.85%.
Fortress Biotech Inc (FBIO) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Fortress Biotech Inc is 20.55%, while institutional ownership is 16.11%. The most recent insider transaction that took place on Sep 23 ’24, was worth 1,404,581. In this transaction PRESIDENT, CEO & CHAIRMAN of this company bought 763,359 shares at a rate of $1.84, taking the stock ownership to the 3,657,264 shares. Before that another transaction happened on Jul 11 ’24, when Company’s President, CEO & Chairman bought 5,000 for $7.48, making the entire transaction worth $37,418. This insider now owns 127,500 shares in total.
Fortress Biotech Inc (FBIO) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.50% during the next five years compared to 22.28% growth over the previous five years of trading.
Fortress Biotech Inc (NASDAQ: FBIO) Trading Performance Indicators
Fortress Biotech Inc (FBIO) is currently performing well based on its current performance indicators. A quick ratio of 1.06 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.27, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -1.48 in one year’s time.
Technical Analysis of Fortress Biotech Inc (FBIO)
Compared to the last year’s volume of 0.41 million, its volume of 0.45 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 12.99%. Additionally, its Average True Range was 0.14.
During the past 100 days, Fortress Biotech Inc’s (FBIO) raw stochastic average was set at 46.06%, which indicates a significant increase from 19.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.36% in the past 14 days, which was lower than the 73.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8304, while its 200-day Moving Average is $1.8420. Nevertheless, the first resistance level for the watch stands at $1.8391 in the near term. At $1.8682, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.9264. If the price goes on to break the first support level at $1.7518, it is likely to go to the next support level at $1.6936. Should the price break the second support level, the third support level stands at $1.6645.
Fortress Biotech Inc (NASDAQ: FBIO) Key Stats
Market capitalization of the company is 49.96 million based on 27,605K outstanding shares. Right now, sales total 84,510 K and income totals -60,640 K. The company made 14,630 K in profit during its latest quarter, and -12,870 K in sales during its previous quarter.
